Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis

Tirath Patela Medicine, American University of Antigua, Antigua and BarbudaCorrespondence[email protected]
View further author information

Fnu Nageetab Medicine, Ghulam Muhammad Mahar Medical College, Sukkur, PakistanView further author information

Rohab Sohailc Medicine, Quaid-e-Azam Medical College Bahawalpur, Pakistan, PakistanView further author information

Tooba Shaukat Buttd Medicine, United Medical and Dental College, Karachi, PakistanView further author information

Shyamala Ganesana Medicine, American University of Antigua, Antigua and BarbudaView further author information

Fnu Madhuritae Medicine, Chanda Medical College, Larkana, PakistanView further author information

Muhammad Ahmedf Medicine, American University of the Carribean, United States of AmericaView further author information

Mahrukh Zafarg Medicine, University of Medicine and health sciences, St. Kitts, Carribean, United States of AmericaView further author information

Wirda Zafarg Medicine, University of Medicine and health sciences, St. Kitts, Carribean, United States of AmericaView further author information

Mohammad Uzair Zamanh Medicine, Bacha Khan Medical College, Mardan, PakistanView further author information

Giustino Varrassii Anesthesiology, Paolo Procacci Foundation, Rome, ItalyView further author information

Mahima Khatrij Medicine, Dow University of Health Sciences, Karachi, Pakistan

Satesh Kumark Medicine, Shaheed Mohtarma Benazir Bhutto Medical College, Karachi, Pakistan

Your download is now in progress and you may close this window